Eloxx Pharmaceuticals vs X4 Pharmaceuticals
ELOX and XFOR side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How ELOX and XFOR compare
X4 Pharmaceuticals is the larger company, worth 5.8 times as much as Eloxx Pharmaceuticals ($309M against $53.1M).
X4 Pharmaceuticals grew revenue faster over the last twelve months (73.7% versus −100% for Eloxx Pharmaceuticals).
Eloxx Pharmaceuticals scores higher on the StockData Score (7 against 3 for X4 Pharmaceuticals), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | ELOX | XFOR |
|---|---|---|
| Size and price | ||
| Market cap | $53.1M | $309M |
| Share price | $13.15 | $3.12 |
| Change, 1 year | 1195350% | −19.4% |
| Change, 5 years | −97.8% | −97.8% |
| Beta (5Y) | – | 1.41 |
| Employees | 7 | 45 |
| StockData Score | ||
| Total score | 7 (better) | 3 |
| Valuation score | 1 (better) | 0 |
| Growth score | 0 | 2 (better) |
| Performance score | 1 (better) | 0 |
| Health score | 5 (better) | 1 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | – | 31.2× |
| P/B | 1.1× (better) | 2.2× |
| Growth | ||
| Revenue growth (TTM) | −100% | 73.7% (better) |
| Revenue growth, 5Y average | – | 16.7% |
| Profitability | ||
| Gross margin | – | 68.8% |
| Operating margin | – | −812% |
| Net margin | – | −813% |
| Return on equity | −54.3% (better) | −80.3% |
| Financial health | ||
| Debt / equity | 0.00 | – |
| Interest coverage | – | −9.3× |
| Current ratio | 3.74 | 13.22 (better) |
| Altman Z-score | −4.40 | −2.09 (better) |
| Piotroski F-score | 3 | 4 (better) |
| Dividends and buybacks | ||
| Buyback yield | 0.00% | – |
| Shareholder yield | 0.00% | 0.00% |
| Ownership | ||
| Held by institutions | 71.8% | 103% |
| Held by insiders | 42.6% | 12.2% |
| Insider net buying, 12 months | – | −$451K |
| Short interest, % of float | 2.3% | 9.2% |
Go deeper
- ELOX stock overview
- ELOX income statement
- ELOX valuation and score
- XFOR stock overview
- XFOR income statement
- XFOR valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.